Strategic partnerships Therapixel is actively expanding through commercial partnerships and integrations with RIS/PACS platforms (RamSoft) and imaging networks (Onsite Women's Health), signaling strong channel opportunities to sell MammoScreen AI within existing enterprise ecosystems.

Prestigious customers Recent client wins include Mayo Clinic and strategic distributors, indicating validation in high-profile healthcare institutions and potential for upsell or expansion within sizable academic and large-network accounts.

Global expansion With activities spanning Paris, Toronto, and North American distribution deals, there is momentum for cross-border deployments and regional go-to-market plays that can be leveraged to target hospital systems and imaging networks worldwide.

AI leadership Therapixel’s track record as a Digital Mammography DREAM Challenge winner and a mature MammoScreen product that leverages prior exams positions it as a trusted AI radiology solution in breast cancer screening, appealing to hospitals seeking proven AI capabilities.

Financial fit Moderate revenue scale matched with substantial funding suggests capacity for accelerated growth and enterprise-grade deployments, presenting opportunities for multi-year procurement contracts and scalable licenses with larger health systems.